The Manitoba government is investing a significant amount into ovarian cancer research over the next few years.
Health, Seniors and Long-Term Care Minister Uzoma Asagwara announced Wednesday that $1 million will be invested over the next three years in research through Ovarian Cancer Canada and the Manitoba Ovarian Cancer Research group.
"This is a strategic and intentional investment that strengthens our commitment to women’s cancer care–an area that has long been under-researched and under-funded," said Asagwara. "By supporting ovarian cancer research, we are empowering our world-class scientists and taking steps toward a future where every woman has access to the care and hope she deserves. Manitoba is proud to lead the way."
Asagwara says the investment will help accelerate the development of local innovations, including novel therapies for chemotherapy-resistant ovarian cancer and experimental tissue resources derived from local patient tumours. It will also strengthen partnerships with the University of Manitoba, CancerCare Manitoba and Ovarian Cancer Canada and bring Manitoba one step closer to establishing an ovarian cancer centre of excellence in Winnipeg.
"This timely investment reinforces the province's commitment to health equity, driving innovation and improving outcomes for women affected with ovarian cancer,” said Asagwara.
Each year, approximately 3,000 Canadians are diagnosed with ovarian cancer, including 110 Manitobans. With a five-year survival rate of only 45 per cent, the disease remains one of the most challenging cancers to treat.